IRB Review of Phase I Research: Balancing Ethics and Efficiency
Phase I research demands careful IRB oversight, balancing participant safety with timely reviews. Proactive strategies can help address its unique challenges.
Phase I research demands careful IRB oversight, balancing participant safety with timely reviews. Proactive strategies can help address its unique challenges.
When an institutional review board (IRB) determines research is “minimal risk” (as defined in Department of Health and Human Services
Learn how to navigate ethical issues in decentralized research with insights for sponsors and IRBs on design and deployment strategies.
Social media can be a valuable tool for researchers to connect with and recruit potential clinical trial participants. However, US regulations
It’s no secret that in clinical research, everything moves at a quick pace – and that doesn’t stop when working
While enrolling subjects is arguably the most crucial aspect of clinical research operations, this cannot be done without activating a
In a recent webinar, Advarra experts Emily Eldh and Ben Shankle provided insights and information in Remote Monitoring: Study Compliance
Discover expert insights on enhancing research inclusivity through improved access, stakeholder relationships, and measurable strategies.
Discover how IQVIA and Advarra accelerated COVID-19 vaccine trials with IBC approvals in under two days, activating sites 71% faster.
In a recent webinar, Advarra experts Constance Cullity and Michele Russell-Einhorn presented FDA Inspections of Clinical Investigators: Understanding the Process
In a recent blog, we described the complexity and uniqueness of Phase I clinical trials, outlining the fact that some
A key element to successful study startup is identifying efficiencies to help meet critical milestones. Engaging with research compliance experts